Literature DB >> 12905013

Paroxetine withdrawal in a neonate with historical and laboratory confirmation.

Sanjay Jaiswal1, Robert C Coombs, Geoffrey K Isbister.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12905013     DOI： 10.1007/s00431-003-1293-9

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN： 0340-6199            Impact factor:   3.183


× No keyword cloud information.
  12 in total

1.  Abnormal monoamine metabolism in cerebrospinal fluid in a case of serotonin syndrome.

Authors:  K Nisijima
Journal:  J Clin Psychopharmacol       Date:  2000-02       Impact factor: 3.153

2.  Neonatal paroxetine withdrawal syndrome.

Authors:  J A Stiskal; N Kulin; G Koren; T Ho; S Ito
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2001-03       Impact factor: 5.747

3.  Neonatal paroxetine withdrawal syndrome or actually serotonin syndrome?

Authors:  G K Isbister; A Dawson; I M Whyte; F H Prior; C Clancy; A J Smith
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2001-09       Impact factor: 5.747

4.  Perinatal outcome following third trimester exposure to paroxetine.

Authors:  Adriana Moldovan Costei; Eran Kozer; Tommy Ho; Shinya Ito; Gideon Koren
Journal:  Arch Pediatr Adolesc Med       Date:  2002-11

Review 5.  A review of the metabolism and pharmacokinetics of paroxetine in man.

Authors:  C M Kaye; R E Haddock; P F Langley; G Mellows; T C Tasker; B D Zussman; W H Greb
Journal:  Acta Psychiatr Scand Suppl       Date:  1989

6.  A comparison of the post-marketing safety of four selective serotonin re-uptake inhibitors including the investigation of symptoms occurring on withdrawal.

Authors:  J S Price; P C Waller; S M Wood; A V MacKay
Journal:  Br J Clin Pharmacol       Date:  1996-12       Impact factor: 4.335

7.  Effects of clomipramine treatment on cerebrospinal fluid monoamine metabolites and platelet 3H-imipramine binding and serotonin uptake and concentration in major depressive disorder.

Authors:  B Mårtensson; A Wägner; O Beck; K Brodin; D Montero; M Asberg
Journal:  Acta Psychiatr Scand       Date:  1991-02       Impact factor: 6.392

8.  The serotonin syndrome scale: first results on validity.

Authors:  U Hegerl; R Bottlender; J Gallinat; H J Kuss; M Ackenheil; H J Möller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1998       Impact factor: 5.270

9.  Fluoxetine hydrochloride (Prozac) toxicity in a neonate.

Authors:  M J Spencer
Journal:  Pediatrics       Date:  1993-11       Impact factor: 7.124

10.  Birth outcomes in pregnant women taking fluoxetine.

Authors:  C D Chambers; K A Johnson; L M Dick; R J Felix; K L Jones
Journal:  N Engl J Med       Date:  1996-10-03       Impact factor: 91.245
View more
  3 in total

1.  Prevalence and patterns of antidepressant drug use during pregnancy.

Authors:  Tessa Ververs; Hans Kaasenbrood; Gerard Visser; Fred Schobben; Lolkje de Jong-van den Berg; Toine Egberts
Journal:  Eur J Clin Pharmacol       Date:  2006-08-08       Impact factor: 2.953

Review 2.  Neonatal Adaptation Issues After Maternal Exposure to Prescription Drugs: Withdrawal Syndromes and Residual Pharmacological Effects.

Authors:  Irma Convertino; Alice Capogrosso Sansone; Alessandra Marino; Maria T Galiulo; Stefania Mantarro; Luca Antonioli; Matteo Fornai; Corrado Blandizzi; Marco Tuccori
Journal:  Drug Saf       Date:  2016-10       Impact factor: 5.606

Review 3.  Treatment with Selective Serotonin Reuptake Inhibitors in the Third Trimester of Pregnancy : Effects on the Infant.

Authors:  Hedvig Nordeng; Olav Spigset
Journal:  Drug Saf       Date:  2005-07       Impact factor: 5.606
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.